Sharyn D. Baker

The genomic landscape of hypodiploid acute lymphoblastic leukemia

Linda Holmfeldt, Lei Wei, Ernesto Díaz-Flores et al. · Nature Genetics · 2013 · 696 citations

Hematological Malignancy, Genomic Landscape, Mixed-phenotype Acute Leukemia +5

CREBBP mutations in relapsed acute lymphoblastic leukaemia

Charles G. Mullighan, Jinghui Zhang, Lawryn H. Kasper et al. · Nature · 2011 · 621 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +4

Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes

Jing Li, Ming Zhao, Ping He et al. · Clinical Cancer Research · 2007 · 303 citations

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991-2001

Sharyn D. Baker, Jaap Verweij, Eric K. Rowinsky et al. · JNCI Journal of the National Cancer Institute · 2002 · 285 citations · Full text

Drug Safety, Investigational Anticancer Agents, Therapeutic Drug Monitoring +13

Irinotecan pathway genotype analysis to predict pharmacokinetics.

Ron H.J. Mathijssen, Sharon Marsh, Mats O. Karlsson et al. · PubMed · 2003 · 258 citations